Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CHODL antisense RNA 2 (CHODL-AS2) is a long non-coding RNA transcribed in the antisense direction relative to the CHODL (chondrolectin) gene locus. As a natural antisense transcript, CHODL-AS2 may regulate the expression of the CHODL gene or other genomic elements via mechanisms such as transcriptional interference, RNA duplex formation, or modulation of chromatin state[1][2]. Antisense RNAs like CHODL-AS2 are generally involved in fine-tuning gene expression, but functional characterization for this specific transcript is lacking, and no experimentally demonstrated role in disease or well-known signaling pathways has been reported in the literature to date[1][2][3].
Antisense-mediated regulation of neighboring (sense) gene expression through base pairing with target mRNA, influencing transcription, RNA stability, or translation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CHODL antisense RNA 2 (CHODL-AS2).